Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-14-Speech-3-034"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-11-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:European Research Area (Multiannual Framework Programme 2002-2006)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20011114.2.3-034"2
lpv:hasSubsequent	lp_eu:2001-11-14-Speech-3-0352
lpv:speaker	lp:Nelly Maes2
lpv:spokenAs	substitute; Committee on Development and Cooperation (1999-07-22--2002-01-14)3 member; Members from the European Parliament to the Joint Parliamentary Assembly of the Agreement between the African, Caribbean and Pacific States and the European Union (ACP-EU) (1999-09-14--2002-01-14)3 unknown; Volksunie (1999-07-20--2002-01-07)3 vice-chair; G/EFA (1999-07-20--2002-01-07)3 member; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)3 substitute; Delegation to the EU-Slovak Republic Joint Parliamentary Committee (1999-10-19--2002-01-14)3
lpv:translated text	"Mr President, Commissioner, ladies and gentlemen, I should like to endorse the congratulations and words of thanks to Mr Caudron. Mr Busquin, the Sixth Framework Programme has the great ambition of establishing a European Research Area, and I truly hope that the small, yet excellent, research teams which we even have in the more peripheral regions will be able to play a role in this. In European research, we must take a step forward both qualitatively and quantitatively speaking. Female researchers must have a part to play in this and in the next few years, forge ahead to take up leading positions in the research programme. Research which attempts to solve the mysteries of life remains important. That is not only applied research, but also fundamental research. There is no doubt that bio-genetics will create new opportunities in future in the fight against incurable diseases, such as Alzheimer’s, Parkinson’s and some forms of cancer. Within the parameters set out in the Caudron report, particularly in Amendment No 22, and under strict ethical supervision, including that of parliaments, we are of the view that it must be possible to finance stem cell research within the Member States’ legal framework. It is of the utmost importance for us to outline this ethical framework and for the European Parliament and the Member State parliaments to follow the developments in this field, for we must avoid at all cost that everything is allowed for some, as long as it is commercially viable, while nothing is allowed for others. We must be led by our conscience to jointly outline this framework, even if we fail to see eye to eye on this matter."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph